Save your place

Sign in to WhoBought

Please try again later.

Cogent Biosciences, Inc. (COGT) institutional ownership

Latest close $38.30 Jul 20, 2026
Market cap$5.6B 52-week range SectorHealthcare
Funds holding · Q1 2026
303
reported COGT position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
185 buyers · 118 sellers

Cogent Biosciences, Inc. (COGT) price and institutional activity

Dates

Q1 2026

$0 bought by 185 investors
VanguardBlackRock +183 more
$0 sold by 118 investors
Fairmount Funds Management LLCDuquesne Family Office LLC +116 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Cogent Biosciences, Inc. (COGT) institutional activity · 303

Investor Type Est. change Change Δ Own Date
Vanguard · Added
Change +4.0M Date Q1 2026
Vanguard Added· Q1 2026 +4.0M Q1 2026
Fairmount Funds Management LLC · Reduced
Change −3.5M Date Q1 2026
Fairmount Funds Management LLC Reduced· Q1 2026 −3.5M Q1 2026
BlackRock · Added
Change +3.1M Date Q1 2026
BlackRock Added· Q1 2026 +3.1M Q1 2026
Goldman Sachs Group Inc · Added
Change +2.7M Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +2.7M Q1 2026
Duquesne Family Office LLC Exited· Q1 2026 −2.2M −100.0% Q1 2026
Rtw Investments, LP · Reduced
Change −2.1M Date Q1 2026
Rtw Investments, LP Reduced· Q1 2026 −2.1M Q1 2026
Kynam Capital Management, LP · Reduced
Change −2.1M Date Q1 2026
Kynam Capital Management, LP Reduced· Q1 2026 −2.1M Q1 2026
Vivo Capital, LLC · Reduced
Change −2.0M Date Q1 2026
Vivo Capital, LLC Reduced· Q1 2026 −2.0M Q1 2026
Invesco Ltd. · Added
Change +1.8M Δ Own +314.8% Date Q1 2026
Invesco Ltd. Added· Q1 2026 +1.8M +314.8% Q1 2026
Pictet Asset Management Holding SA · Added
Change +1.7M Date Q1 2026
Pictet Asset Management Holding SA Added· Q1 2026 +1.7M Q1 2026
Janus Henderson Group PLC · Added
Change +1.4M Date Q1 2026
Janus Henderson Group PLC Added· Q1 2026 +1.4M Q1 2026
Lord, Abbett & Co. LLC · Added
Change +1.3M Date Q1 2026
Lord, Abbett & Co. LLC Added· Q1 2026 +1.3M Q1 2026
Vestal Point Capital, LP · New
Change +1.2M Date Q1 2026
Vestal Point Capital, LP New· Q1 2026 +1.2M Q1 2026
Holocene Advisors, LP · Added
Change +1.1M Date Q1 2026
Holocene Advisors, LP Added· Q1 2026 +1.1M Q1 2026
Tcg Crossover Management, LLC · Reduced
Change −921K Date Q1 2026
Tcg Crossover Management, LLC Reduced· Q1 2026 −921K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 303

Famous investor activity in Cogent Biosciences, Inc. (COGT)

Cogent Biosciences, Inc. (COGT) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Ferrante Karen Jean · Director Grant (A) 627
Owned 627 Trade date Jul 1, 2026 Filed date Jul 6, 2026
Ferrante Karen Jean Director Grant (A) 627 627 Jul 1, 2026 Jul 6, 2026
Harwin Peter Evan · Director Grant (A) 18K
Owned 18K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Harwin Peter Evan Director Grant (A) 18K 18K Jun 9, 2026 Jun 11, 2026
Ferrante Karen Jean · Director Grant (A) 18K
Owned 18K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Ferrante Karen Jean Director Grant (A) 18K 18K Jun 9, 2026 Jun 11, 2026
Cain Christopher W. · Director Grant (A) 18K
Owned 18K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Cain Christopher W. Director Grant (A) 18K 18K Jun 9, 2026 Jun 11, 2026
Shegog Todd · Director Grant (A) 18K
Owned 18K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Shegog Todd Director Grant (A) 18K 18K Jun 9, 2026 Jun 11, 2026
Morris Arlene · Director Grant (A) 18K
Owned 18K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Morris Arlene Director Grant (A) 18K 18K Jun 9, 2026 Jun 11, 2026
Ros Matthew · Director Grant (A) 18K
Owned 18K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Ros Matthew Director Grant (A) 18K 18K Jun 9, 2026 Jun 11, 2026
Robbins Andrew R. · Director 2 operations 0
Owned 160K Trade date May 19, 2026 Filed date May 21, 2026
Robbins Andrew R. Director 2 operations 0 160K May 19, 2026 May 21, 2026
Ferrante Karen Jean · Director Grant (A) 686
Owned 686 Trade date Apr 1, 2026 Filed date Apr 3, 2026
Ferrante Karen Jean Director Grant (A) 686 686 Apr 1, 2026 Apr 3, 2026
Fairmount Funds Management LLC · Director Sell −$243M
Price $34.66 Qty −7.0M Owned 5.5M Trade date Mar 31, 2026 Filed date Mar 31, 2026
Fairmount Funds Management LLC Director Sell $34.66 −7.0M −$243M 5.5M Mar 31, 2026 Mar 31, 2026
Fairmount Funds Management LLC · Director 2 operations 7.0M
Owned 39K Trade date Mar 31, 2026 Filed date Mar 31, 2026
Fairmount Funds Management LLC Director 2 operations 7.0M 39K Mar 31, 2026 Mar 31, 2026
Fairmount Funds Management LLC · Director Sell −$127M
Price $36.40 Qty −3.5M Owned 5.5M Trade date Jan 22, 2026 Filed date Jan 22, 2026
Fairmount Funds Management LLC Director Sell $36.40 −3.5M −$127M 5.5M Jan 22, 2026 Jan 22, 2026
Ferrante Karen Jean · Director Grant (A) 643
Owned 643 Trade date Jan 1, 2026 Filed date Jan 5, 2026
Ferrante Karen Jean Director Grant (A) 643 643 Jan 1, 2026 Jan 5, 2026
Kearns Evan · Officer Sell −$2.5M
Price $38.70 Qty −65K Owned 109K Trade date Dec 26, 2025 Filed date Dec 30, 2025
Kearns Evan Officer Sell $38.70 −65K −$2.5M 109K Dec 26, 2025 Dec 30, 2025
Green John L. · Officer Sell −$3.0M
Price $38.68 Qty −77K Owned 132K Trade date Dec 26, 2025 Filed date Dec 30, 2025
Green John L. Officer Sell $38.68 −77K −$3.0M 132K Dec 26, 2025 Dec 30, 2025
15 of 30
15 of 30 Sign in to continue to older insider transactions.

Cogent Biosciences, Inc. (COGT) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
FMR LLC 13.2M
% of shares outstanding 12.1% Filing date Nov 7, 2024
FMR LLC 13.2M 12.1% Nov 7, 2024
Venrock Healthcare Capital Partners Ii, L.P. 115.2M
% of shares outstanding 10.0% Filing date Nov 14, 2024
Venrock Healthcare Capital Partners Ii, L.P. 115.2M 10.0% Nov 14, 2024
Point72 Asset Management, L.P. 15.1M
% of shares outstanding 9.9% Filing date Nov 14, 2024
Point72 Asset Management, L.P. 15.1M 9.9% Nov 14, 2024
Fairmount Funds Management LLC 11.3M
% of shares outstanding 9.9% Filing date Jun 13, 2024
Fairmount Funds Management LLC 11.3M 9.9% Jun 13, 2024
Commodore Capital LP 10.5M
% of shares outstanding 9.3% Filing date Nov 14, 2024
Commodore Capital LP 10.5M 9.3% Nov 14, 2024
Kynam Capital Management, LP 9.2M
% of shares outstanding 8.4% Filing date Nov 14, 2024
Kynam Capital Management, LP 9.2M 8.4% Nov 14, 2024
Flynn James E 9.0M
% of shares outstanding 5.3% Filing date May 14, 2026
Flynn James E 9.0M 5.3% May 14, 2026
Suvretta Capital Management, LLC
% of shares outstanding 0.0% Filing date Nov 14, 2024
Suvretta Capital Management, LLC 0.0% Nov 14, 2024
8 of 9

Cogent Biosciences, Inc. (COGT) ownership FAQ

Who owns COGT?

303 reporting institutions disclosed COGT position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.